Unlocking mRNA Vaccine, Therapeutics & Platform Technologies from Discovery to Commercialization With Targeted Extrahepatic Delivery, Dose Longevity & Improved Safety for Oncology, Rare & Infectious Diseases & Beyond
The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidates and developmental progress towards clinical and commercial approval.
To shine light on emerging areas and the latest progress, the 5th mRNA-Based Therapeutics Summit returns to Boston as the world's largest, end-to-end mRNA conference, gathering 320+ global stakeholders, sharing exclusive scientific and strategic insights from the biggest and newest players in the mRNA, Circular RNA & Self-Amplifying RNA fields including Moderna, Pfizer, BioNTech, Grann Pharmaceuticals, Celestial Therapeutics, Byterna Therapeutics and more.
Discover the realms of new infectious disease platforms, combating oncological targets and cell therapies across 4 dedicated tracks of content in Discovery, Pre-Clinical Development, Clinical Development and, Manufacturing & CMC as your one-stop-shop scientific content and partnering forum to aid the progress of pipelines in 2025 towards the clinic and ultimately patients in need.
Snapshot of World Class Speakers:
Attending Companies Include








Room Block
We are pleased to announce that for 5th mRNA-Based Therapeutics Summit we have a dedicated room block at the conference hotel, The Westin Boston Seaport District. More information can be found here. Rooms are limited – we recommend booking soon to avoid disappointment.

Poster Session
Showcase your exciting mRNA science at the 2025 Poster Session to collaborate, engage and share progress with the field. Details on poster submissions can be found here.